Ipca Laboratories Ltd. — Capital/Financing Update 2021

Jun 11, 2021

THRU ONLINE FILING

June 11, 2021

BSE Ltd. Phiroze Jeejeebhoy Towers Dalai Street Mumbai 400 023 Scrip Code - 524494

National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra -(East). Mumbai-400051. Scrip Code: IPCALAB

Dear Sirs,

Re: Acquisition of further 13.09% of the paid-up equity share capital of M/s. Trophic Wellness Pvt. Ltd. fTWPU

We are pleased to inform you that the Company has acquired further 13.09% of the paid-up equity share capital of M/s. Trophic Wellness Private Ltd. (TWPL), a company incorporated under the Companies Act, 1956 and engaged in the business of manufacturing and marketing several SKUs of Neutraceuticals underthe brand name "Nutricharge".

With this acquisition of these 13.09% of the equity share capital, the said M/s. Trophic Wellness Pvt. Ltd. has become a subsidiary of the Company. The Company now holds 52.35% of the paid-up equity share capital of TWPL.

The required disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed herewith.

Thanking you

Yours faithfully For Ipca Laboratories Limited

Harish P. Kamath Corporate Counsel & Company Se

Enel: a/a

Ipca Laboratories Ltd. www.ipca.com

125, Kandivli Industrial Estate, CIS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T:+91 22 62105000 F:+91 22 62105005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6647 4444 E: ipca@ipca.com ON: L24239MH1949PLC007837

DISCLOSURE UNDER REGULATION 30 OF SEB1 (LISTING OBLIGATIONS AND

DISCLOSURE REQUIREMENTS) REGULATIONS, 2015

ACQUISITION OF FURTHER 13.09% OF THE PAID-UP SHARE CAPITAL OF M/S. TROPHIC WELLNESS PVT. LTD. (TWPL)

a.	Name of the target entity, details in briefsuch as size, turnover etc	Trophic Wellness Pvt. Ltd. (TWPL)(CIN U24100MH2010P7C206526)142-AB, Kandivli Industrial EstateKandivli (West), Mumbai -400 067For the financial year ended 31st March 2021:
		: Rs. 102.82 croresTotal Income32.91 croresEBIDTA: Rs.Profit Before Tax : Rs.30.70 croresProfit After Tax21.76 crores: Rs.
		TWPLengagedthe. businessofisinmanufacturing and marketing of several SKUs oftheNeutraceuticalsunderbrandname"'Nutricharge".company'sThemanufacturingfacility is situated at Sikkim.TWPL is debt free.
b.	Whether the acquisition would fall withinrelated party transaction(s) and whetherthe promoter/ promoter group/ groupcompanies have any interest in theentity being acquired? If yes, nature ofinterest and details thereof and whetherthe same is done at "arms length"	This acquisition does not fall within the relatedpromoter /thepartytransactionandpromotergroup/ group companies have no interest in theshares being acquired.
c.	Industry to which the entity beingacquired belongs	TWPLengagedthebusinessinofismanufacturing and marketing of several SKUs ofNeutraceuticalsunderthebrandname"Nutricharge".
d.	Objects and effects of acquisition(including but not limited to, disclosureof reasons for acquisition of targetentity, if its business is outside the mainline of business of the listed entity)	With the acquisition of these further shares, TWPLhas now become Company's subsidiary. This willhelptheCompanytogrowneutraceuticalsitsportfolio and business.
e.	Brief details of any governmental orregulatory approvals required for theacquisition__________	Prior governmental or regulatory approval is notrequired for this acquisition.
f.	Indicative time period forcompletion ofthe acquisition	This acquisition is made on 11,hJune, 2021.

Ipca Laboratories Ltd. www.ipca.com

1>§sJ^n^ivij.indysfrial Estate,CIS No.328,Kandivli (West), Mumbai400067(Maharashtra), india | T:+91 22 62105000 F:+91 22 62105005. ^ 1 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6647 4444 E: ipca@ipca.com CIN: L24239MH1949PLC007837

9-	Nature of consideration - whethercash consideration or share swapand details ofthesame	Cash Consideration of Rs. 21.20 crores for 5,30,000equity shares of TWPL acquired@ Rs. 400/-pershare.
h.	Cost of acquisition orthe price atwhich the shares are acquired	Cash Consideration of Rs. 21.20 crores was paid forthe additional acquisition of13.09% shareholding ofTWPL -equity5,30,000shares@400/-perRs.share.
	Percentage of shareholding /control acquired and /or number ofshares acquired	ofWiththisadditionalacquisitionof13.09%shareholdingtheCompanyTWPL,nowholdsinTWPL52.35%TWPL.hasnowbecomeinasubsidiary ofthe Company.
J	Brief background aboutthe entityacquired in terms of products/lineof business acquired, date ofincorporation, history of last 3years turnover, country in whichthe acquired entity has presenceand any other significantinformation (in brief)	TrophicWellnessPvt.(TWPL),acompanyLtd.incorporated in the year 2010 under the Companies1956andisengagedthebusinessofAct,inofmanufacturingandmarketingseveralSKUsofNeutraceuticals under the brandname "Nutriqharge".The Company'smanufacturing facility is situated atSikkim.The registered office of the Company is situated atPlotKandivliIndustrial142-AB,Estate,Kandivli(West), Mumbai -400,067.The financial of TWPL are as under:
		(Financial year ended 31st March)	Rs. Crores)
			20202021		2019
			(Audited)	(Audited)	(Audited)
		Total Income	102.82	85.74	70.34
		EBIDTA	32.91	24.51	.15.67
		Profit beforeTax	30.70	21.96	12.42
		Provision forTax	8.93	6.44	(0.43)
		Profit after tax	21.77	15.52	12.85
		EPS	53.74	38.32	31.73
		Share Capital	4.05	4.05	4.05
		Reserves &Surplus	80.36	58.58	63.12
		Net worth	84.41	62.63	67.16
		TWPL is debtfree.

;

Ipca Laboratories Ltd.

www.ipca.com

125, Kandivli Industrial Estate,CTS No.328, Kandivli (West), Mumbai400067(Maharashtra), India | T:+91 22 62105000 R+91 22 62105005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6647 4444 E: ipca@ipca.com CIN: L24239MH1949PLC007837